Q2 2026 saw a 4% organic sales decline due to weak European demand and inflation, but North America grew across all divisions. EBITDA margin improved to 13.6%, with strong cash flow and accelerated cost savings. Strategic actions included supplier consolidation, manufacturing shifts, and a business unit exit.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.